399 related articles for article (PubMed ID: 22704703)
1. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment.
Quan EM; Li X; Li Y; Wang X; Kudchadker RJ; Johnson JL; Kuban DA; Lee AK; Zhang X
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1169-78. PubMed ID: 22704703
[TBL] [Abstract][Full Text] [Related]
2. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer.
Davidson MT; Blake SJ; Batchelar DL; Cheung P; Mah K
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1550-8. PubMed ID: 21543164
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of biological versus physical optimization for single-arc VMAT for prostate and head and neck cases.
Pyshniak V; Fotina I; Zverava A; Siamkouski S; Zayats E; Kopanitsa G; Okuntsau D
J Appl Clin Med Phys; 2014 Jul; 15(4):4514. PubMed ID: 25207394
[TBL] [Abstract][Full Text] [Related]
4. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
5. VMAT partial arc technique decreases dose to organs at risk in whole pelvic radiotherapy for prostate cancer when compared to full arc VMAT and IMRT.
Bartlett GK; Njeh CF; Huang KC; DesRosiers C; Guo G
Med Dosim; 2023 Spring; 48(1):8-15. PubMed ID: 36319515
[TBL] [Abstract][Full Text] [Related]
6. Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial.
Jaccard M; Zilli T; Dubouloz A; Escude L; Jorcano S; Linthout N; Bral S; Verbakel W; Bruynzeel A; Björkqvist M; Minn H; Tsvang L; Symon Z; Lencart J; Oliveira A; Ozen Z; Abacioglu U; Pérez-Moreno JM; Rubio C; Rouzaud M; Miralbell R
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1047-1054. PubMed ID: 32535161
[TBL] [Abstract][Full Text] [Related]
7. A knowledge-based approach to improving and homogenizing intensity modulated radiation therapy planning quality among treatment centers: an example application to prostate cancer planning.
Good D; Lo J; Lee WR; Wu QJ; Yin FF; Das SK
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):176-81. PubMed ID: 23623460
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
[TBL] [Abstract][Full Text] [Related]
9. Conformal irradiation of concave-shaped PTVs in the treatment of prostate cancer by simple 1D intensity-modulated beams.
Fiorino C; Broggi S; Corletto D; Cattaneo GM; Calandrino R
Radiother Oncol; 2000 Apr; 55(1):49-58. PubMed ID: 10788688
[TBL] [Abstract][Full Text] [Related]
10. Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer.
Pasler M; Georg D; Wirtz H; Lutterbach J
Strahlenther Onkol; 2011 Dec; 187(12):792-8. PubMed ID: 22127357
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Dose Control and Optimization Strategy for Left Breast Cancer Radiotherapy With Non-Uniform VMAT Technology.
Qiu J; Zhang S; Lv B; Zheng X
Technol Cancer Res Treat; 2021; 20():15330338211053752. PubMed ID: 34806481
[No Abstract] [Full Text] [Related]
13. Comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy prostate cancer plans accounting for cold spots.
Nguyen TTT; Arimura H; Asamura R; Hirose TA; Ohga S; Fukunaga JI
Radiol Phys Technol; 2019 Jun; 12(2):137-148. PubMed ID: 30805779
[TBL] [Abstract][Full Text] [Related]
14. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.
Pasquier D; Cavillon F; Lacornerie T; Touzeau C; Tresch E; Lartigau E
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):549-54. PubMed ID: 22677369
[TBL] [Abstract][Full Text] [Related]
15. Biological optimization in volumetric modulated arc radiotherapy for prostate carcinoma.
Mihaylov IB; Fatyga M; Bzdusek K; Gardner K; Moros EG
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1292-8. PubMed ID: 21570214
[TBL] [Abstract][Full Text] [Related]
16. Impact of gantry rotation time on plan quality and dosimetric verification--volumetric modulated arc therapy (VMAT) vs. intensity modulated radiotherapy (IMRT).
Pasler M; Wirtz H; Lutterbach J
Strahlenther Onkol; 2011 Dec; 187(12):812-9. PubMed ID: 22127360
[TBL] [Abstract][Full Text] [Related]
17. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
[TBL] [Abstract][Full Text] [Related]
18. Multicriteria optimization informed VMAT planning.
Chen H; Craft DL; Gierga DP
Med Dosim; 2014; 39(1):64-73. PubMed ID: 24360919
[TBL] [Abstract][Full Text] [Related]
19. Quality of treatment plans and accuracy of in vivo portal dosimetry in hybrid intensity-modulated radiation therapy and volumetric modulated arc therapy for prostate cancer.
Bedford JL; Smyth G; Hanson IM; Tree AC; Dearnaley DP; Hansen VN
Radiother Oncol; 2016 Aug; 120(2):320-6. PubMed ID: 27470308
[TBL] [Abstract][Full Text] [Related]
20. Fully automated, multi-criterial planning for Volumetric Modulated Arc Therapy - An international multi-center validation for prostate cancer.
Heijmen B; Voet P; Fransen D; Penninkhof J; Milder M; Akhiat H; Bonomo P; Casati M; Georg D; Goldner G; Henry A; Lilley J; Lohr F; Marrazzo L; Pallotta S; Pellegrini R; Seppenwoolde Y; Simontacchi G; Steil V; Stieler F; Wilson S; Breedveld S
Radiother Oncol; 2018 Aug; 128(2):343-348. PubMed ID: 29970259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
